Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L)

EUR 62.2

(0.97%)

Eps Summary of Laboratorios Farmaceuticos Rovi, S.A.

Laboratorios Farmaceuticos Rovi, S.A.'s latest annual eps in 2023 was 3.20 EUR , down -14.21% from previous year.
Laboratorios Farmaceuticos Rovi, S.A.'s latest quarterly eps in 2024 Q2 was 0.55 EUR , up 89.66% from previous quarter.
Laboratorios Farmaceuticos Rovi, S.A. reported an annual eps of 3.73 EUR in 2022, up 35.14% from previous year.
Laboratorios Farmaceuticos Rovi, S.A. reported an annual eps of 2.76 EUR in 2021, up 150.91% from previous year.
Laboratorios Farmaceuticos Rovi, S.A. reported a quarterly eps of 0.29 EUR for 2024 Q1, down -70.71% from previous quarter.
Laboratorios Farmaceuticos Rovi, S.A. reported a quarterly eps of 0.89 EUR for 2023 Q1, down -39.04% from previous quarter.

Annual Eps Chart of Laboratorios Farmaceuticos Rovi, S.A. (2023 - 2012)

Historical Annual Eps of Laboratorios Farmaceuticos Rovi, S.A. (2023 - 2012)

Year	Eps	Eps Growth
2023	3.20 EUR	-14.21%
2022	3.73 EUR	35.14%
2021	2.76 EUR	150.91%
2020	1.10 EUR	54.93%
2019	0.71 EUR	102.86%
2018	0.35 EUR	0.0%
2017	0.35 EUR	-33.96%
2016	0.53 EUR	32.5%
2015	0.40 EUR	-16.67%
2014	0.48 EUR	4.35%
2013	0.46 EUR	17.95%
2012	0.39 EUR	0.0%

Year	Eps	Eps Growth
2024 Q2	0.55 EUR	89.66%
2024 Q1	0.29 EUR	-70.71%
2023 Q1	0.89 EUR	-39.04%
2023 Q2	0.36 EUR	-59.55%
2023 Q3	0.98 EUR	172.22%
2023 Q4	0.99 EUR	1.02%
2023 FY	- EUR	-11.8%
2022 Q4	1.46 EUR	82.5%
2022 Q3	0.80 EUR	53.85%
2022 FY	- EUR	35.14%
2022 Q2	0.52 EUR	-46.39%
2022 Q1	0.97 EUR	-2.02%
2021 Q2	0.49 EUR	13.95%
2021 Q4	0.99 EUR	15.12%
2021 Q3	0.86 EUR	75.51%
2021 Q1	0.43 EUR	65.38%
2021 FY	- EUR	150.91%
2020 Q1	- EUR	-100.0%
2020 Q4	0.26 EUR	0.0%
2020 Q3	- EUR	-100.0%
2020 FY	- EUR	54.93%
2020 Q2	0.28 EUR	0.0%
2019 FY	- EUR	102.86%
2019 Q4	0.16 EUR	0.0%
2019 Q3	- EUR	-100.0%
2019 Q2	0.17 EUR	0.0%
2019 Q1	- EUR	-100.0%
2018 Q4	0.04 EUR	0.0%
2018 Q3	- EUR	-100.0%
2018 Q2	0.01 EUR	0.0%
2018 Q1	- EUR	-100.0%
2018 FY	- EUR	0.0%
2017 Q3	- EUR	-100.0%
2017 Q1	- EUR	-100.0%
2017 FY	- EUR	-33.96%
2017 Q4	0.00 EUR	0.0%
2017 Q2	0.19 EUR	0.0%
2016 Q2	0.17 EUR	0.0%
2016 FY	- EUR	32.5%
2016 Q4	0.09 EUR	0.0%
2016 Q3	- EUR	-100.0%
2016 Q1	- EUR	-100.0%
2015 FY	- EUR	-16.67%
2015 Q4	0.07 EUR	0.0%
2015 Q3	- EUR	-100.0%
2015 Q2	0.14 EUR	0.0%
2015 Q1	- EUR	-100.0%
2014 Q4	0.09 EUR	0.0%
2014 FY	- EUR	4.35%
2014 Q1	- EUR	-100.0%
2014 Q2	0.18 EUR	0.0%
2014 Q3	- EUR	-100.0%
2013 Q2	0.17 EUR	0.0%
2013 Q4	0.09 EUR	0.0%
2013 FY	- EUR	17.95%
2013 Q3	- EUR	-100.0%
2013 Q1	- EUR	-100.0%
2012 Q4	0.06 EUR	0.0%
2012 FY	- EUR	0.0%

Peer Eps Comparison of Laboratorios Farmaceuticos Rovi, S.A.

Name	Eps	Eps Difference
Boiron SA	2.06 EUR	-55.34%
Vetoquinol SA	4.70 EUR	31.915%
Valneva SE	-0.73 EUR	538.356%
AB Science S.A.	-0.20 EUR	1700.0%
Nanobiotix S.A.	-1.08 EUR	396.296%
PHAXIAM Therapeutics S.A.	-5.00 EUR	164.0%
Vivoryon Therapeutics N.V.	-1.12 EUR	385.714%
BioSenic S.A.	-0.21 EUR	1623.81%
ABIVAX Société Anonyme	-3.43 EUR	193.294%
Formycon AG	4.76 EUR	32.773%